Influenza Vaccine
The global Influenza Vaccine market was valued at 323.34 Million USD in 2021 and will grow with a CAGR of 7.18% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes.
By Market Verdors
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech
By Types
Trivalent
Quadrivalent
By Applications
Adults
Pediatrics
Key Indicators Analysed
Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.
Opportunities and DriversIdentifying the Growing Demands and New Technology
Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Influenza Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Influenza Vaccine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Trivalent
1.4.3 Quadrivalent
1.5 Market by Application
1.5.1 Global Influenza Vaccine Market Share by Application: 2022-2027
1.5.2 Adults
1.5.3 Pediatrics
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Influenza Vaccine Market
1.8.1 Global Influenza Vaccine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Influenza Vaccine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Influenza Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Influenza Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Influenza Vaccine Sales Volume Market Share by Region (2016-2021)
3.2 Global Influenza Vaccine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Influenza Vaccine Sales Volume
3.3.1 North America Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Influenza Vaccine Sales Volume
3.4.1 East Asia Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Influenza Vaccine Sales Volume (2016-2021)
3.5.1 Europe Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Influenza Vaccine Sales Volume (2016-2021)
3.6.1 South Asia Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Influenza Vaccine Sales Volume (2016-2021)
3.7.1 Southeast Asia Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Influenza Vaccine Sales Volume (2016-2021)
3.8.1 Middle East Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Influenza Vaccine Sales Volume (2016-2021)
3.9.1 Africa Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Influenza Vaccine Sales Volume (2016-2021)
3.10.1 Oceania Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Influenza Vaccine Sales Volume (2016-2021)
3.11.1 South America Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Influenza Vaccine Sales Volume (2016-2021)
3.12.1 Rest of the World Influenza Vaccine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Influenza Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Influenza Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Influenza Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Influenza Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Influenza Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Influenza Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Influenza Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Influenza Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Influenza Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Influenza Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Influenza Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Influenza Vaccine Sales Volume Market Share by Type (2016-2021)
14.2 Global Influenza Vaccine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Influenza Vaccine Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Influenza Vaccine Consumption Volume by Application (2016-2021)
15.2 Global Influenza Vaccine Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Influenza Vaccine Business
16.1 AstraZeneca
16.1.1 AstraZeneca Company Profile
16.1.2 AstraZeneca Influenza Vaccine Product Specification
16.1.3 AstraZeneca Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 CSL
16.2.1 CSL Company Profile
16.2.2 CSL Influenza Vaccine Product Specification
16.2.3 CSL Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 GlaxoSmithKline
16.3.1 GlaxoSmithKline Company Profile
16.3.2 GlaxoSmithKline Influenza Vaccine Product Specification
16.3.3 GlaxoSmithKline Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Sanofi
16.4.1 Sanofi Company Profile
16.4.2 Sanofi Influenza Vaccine Product Specification
16.4.3 Sanofi Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Altimmune
16.5.1 Altimmune Company Profile
16.5.2 Altimmune Influenza Vaccine Product Specification
16.5.3 Altimmune Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 BionVax
16.6.1 BionVax Company Profile
16.6.2 BionVax Influenza Vaccine Product Specification
16.6.3 BionVax Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 FluGen
16.7.1 FluGen Company Profile
16.7.2 FluGen Influenza Vaccine Product Specification
16.7.3 FluGen Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 FOLIA BIOTECH
16.8.1 FOLIA BIOTECH Company Profile
16.8.2 FOLIA BIOTECH Influenza Vaccine Product Specification
16.8.3 FOLIA BIOTECH Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Genentech
16.9.1 Genentech Company Profile
16.9.2 Genentech Influenza Vaccine Product Specification
16.9.3 Genentech Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Influenza Vaccine Manufacturing Cost Analysis
17.1 Influenza Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Influenza Vaccine
17.4 Influenza Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Influenza Vaccine Distributors List
18.3 Influenza Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Influenza Vaccine (2022-2027)
20.2 Global Forecasted Revenue of Influenza Vaccine (2022-2027)
20.3 Global Forecasted Price of Influenza Vaccine (2016-2027)
20.4 Global Forecasted Production of Influenza Vaccine by Region (2022-2027)
20.4.1 North America Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.9 South America Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Influenza Vaccine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Influenza Vaccine by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Influenza Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Influenza Vaccine by Country
21.3 Europe Market Forecasted Consumption of Influenza Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Influenza Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Influenza Vaccine by Country
21.6 Middle East Forecasted Consumption of Influenza Vaccine by Country
21.7 Africa Forecasted Consumption of Influenza Vaccine by Country
21.8 Oceania Forecasted Consumption of Influenza Vaccine by Country
21.9 South America Forecasted Consumption of Influenza Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Influenza Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices